HIV Populations
U.N. AIDS Meeting Calls for More Treatment Access, Fewer Child Infections
- Details
- Category: Pregnancy & HIV MTCT
- Published on Friday, 17 June 2011 01:14
- Written by UNAIDS
World leaders at a U.N. High Level Meeting on AIDS last week adopted a consensus declaration setting targets for global universal access to antiretroviral therapy and elimination of mother-to-child HIV transmission.
Report Looks at HIV/AIDS among Latino Gay Men
- Details
- Category: Gay & Bisexual Men/MSM
- Published on Monday, 02 May 2011 18:30
- Written by HIVandHepatitis.com
NASTAD recently released a report on challenges facing U.S. Latino gay men in relation to HIV/AIDS and access to care.
CROI 2011: Do Black Patients Respond Less Well to Antiretroviral Therapy?
- Details
- Category: Race/Ethnicity
- Published on Friday, 25 March 2011 01:45
- Written by Liz Highleyman
African-Americans had a 40% greater likelihood of virological failure on antiretroviral therapy even after controlling for known risk factors, according to a meta-analysis of ACTG trials presented at CROI 2011.
NIH Office of AIDS Research Looks at Aging with HIV
- Details
- Category: HIV & Aging
- Published on Thursday, 28 April 2011 21:37
- Written by NIH
The National Institutes of Health's Office of AIDS Research (OAR) recently held a meeting of experts to review information about HIV and aging and formulate a research agenda.
First-line NNRTI and Protease Inhibitor Regimens Work Equally Well for Children with HIV
- Details
- Category: Children & Adolescents
- Published on Friday, 25 February 2011 02:10
- Written by Liz Highleyman
Initial antiretroviral therapy (ART) regimens containing protease inhibitors and those with non-nucleoside reverse transcriptase inhibitors (NNRTIs) both produced good outcomes for children with HIV, according to research published in the February 1, 2011 advance online edition of Lancet Infectious Diseases. Viral load dropped by a similar amount, but children who started on NNRTIs and those who waited longer to switch were more likely to develop drug resistance.